Abstract
Aim
Phloroglucinol is a musculotropic anti-spasmodic drug. It is frequently prescribed in many European countries with a considerable cost for health services. The purpose of this study was to review the existing randomised controlled trials (RCT) comparing the efficacy of phloroglucinol treating abdominal pain versus placebo.
Methods
A literature search was carried out up to May 2017 to select RCT comparing the effect of phloroglucinol versus placebo with intensity of abdominal pain as an endpoint. Studies concerning obstetric or gynaecologic-related pain were not included.
Results
Three RCT were included and then analysed for risk of bias and meta-analysed. Only one RCT found that phloroglucinol was superior to placebo, although with a high risk of bias. The meta-analysis found a risk ratio of 1.10 (95% CI 0.95, 1.27) with no statistical significance.
Discussion
There is insufficient data to justify the wide-spread prescription of phloroglucinol for alleviating abdominal pain.
Similar content being viewed by others
References
Annaházi A, Róka R, Rosztóczy A, Wittmann T (2014) Role of antispasmodics in the treatment of irritable bowel syndrome. World J Gastroenterol 20(20):6031–6043. https://doi.org/10.3748/wjg.v20.i20.6031
Vademecum (2010) Equivalencias internacionales: phloroglucinol. http://www.vademecum.es/equivalencia-lista-spasmex+tablet+80+mg+80+mg-italia-a03ax12-it_1. Accessed 13 Jun 2017
Cahen R (1962) Phloroglucinol: a pharmacological reevaluation. Smooth muscle relaxing properties. Arch Int Pharmacodyn Ther 138:311–319
Base de données publiques des médicaments (2016) Résumé des caractéristiques du produit Phloroglucinol EG 80 mg. http://base-donnees-publique.medicaments.gouv.fr/affichageDoc.php?specid=60399956&typedoc=R. Accessed 13 Jun 2017
Sasaki D, Kido A, Yoshida Y (1984) Effect of antispasmodic drugs on colonic motility. Part I: laboratory study of the dog. Int J Clin Pharmacol Ther Toxicol 22:333–337
Subissi A, Brunori P, Bachi M (1983) Effects of spasmolytics on K+−induced contraction of rat intestine in vivo. Eur J Pharmacol 96(3-4):295–301. https://doi.org/10.1016/0014-2999(83)90320-5
Vidal (2017) Médicaments par substance active: phloroglucinol. https://www.vidal.fr/Substance/phloroglucinol-3760.htm. Accessed 5 Jun 2017
HAS (Haute autorité de santé) (2014) Commission de la Transparence, Avis 17 septembre 2014 Spasfon. https://www.has-sante.fr//portail/upload/docs/evamed/CT-12373_SPASFON_RI_Avis2_CT12373.pdf. Accessed 5 Jun 2017
Medic’AM (2016) Données mensuelles et annuelles sur les médicaments remboursés par l’Assurance Maladie. https://www.ameli.fr/l-assurance-maladie/statistiques-et-publications/donnees-statistiques/medicament/medic-am/medic-am-mensuel-2016.php. Accessed 31 May 2017
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339(jul21 1):b2535. https://doi.org/10.1136/bmj.b2535
Parab S, Bhalerao S (2010) Study designs. Int J Ayurveda Res 1(2):128–131. https://doi.org/10.4103/0974-7788.64406
Higgins J, Altman D, Gøtzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343(oct18 2):d5928. https://doi.org/10.1136/bmj.d5928
Wu Z-S, Liu LB, Tang G-H, Deng Q-L (2012) Efficacy of phloroglucinol in the treatment of patients after surgery for mixed hemorrhoid. World Chinese J Dig 1259–1262
Cha BK, Choi CH, Kim BJ et al (2011) The effect of phloroglucinol in diarrhea-dominant irritable bowel syndrome: randomized, double-blind, placebo-controlled trial. Gastroenterology 140:611. https://doi.org/10.1016/S0016-5085(11)62529-8
Boubaker H, Boukef R, Claessens YE, Bouida W, Grissa MH, Beltaief K, Trimech MN, Kerkeni W, Boudhib L, Nouira S (2010) Phloroglucinol as an adjuvant analgesic to treat renal colic. Am J Emerg Med 28(6):720–723. https://doi.org/10.1016/j.ajem.2009.04.030
Fu W, Yao J, Li Q, Wang Y, Wu X, Zhou Z, Li WB, Yan JA (2014) Efficacy and safety of Parecoxib/Phloroglucinol combination therapy versus Parecoxib monotherapy for acute renal colic: a randomized, double-blind clinical trial. Cell Biochem Biophys 69(1):157–161. https://doi.org/10.1007/s12013-013-9782-6
Chassany O, Bonaz B, Bruley DES Varannes S et al (2007) Acute exacerbation of pain in irritable bowel syndrome: efficacy of phloroglucinol/trimethylphloroglucinol. A randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther 25(9):1115–1123. https://doi.org/10.1111/j.1365-2036.2007.03296.x
Association Mieux Prescrire (2010) Phloroglucinol: réactions allergiques graves. La Rev Prescrire 30:114
Committee for the Proprietary Medicinal Products (CPMP) (2002) Note for guidance on clinical investigation of medicinal products for treatment of nociceptive pain. Eur. Agency Eval. Med. Prod
Tashjian RZ, Deloach J, Porucznik CA, Powell AP (2009) Minimal clinically important differences (MCID) and patient acceptable symptomatic state (PASS) for visual analog scales (VAS) measuring pain in patients treated for rotator cuff disease. J Shoulder Elb Surg 18(6):927–932. https://doi.org/10.1016/j.jse.2009.03.021
Gerlinger C, Schumacher U, Faustmann T et al (2010) Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials. https://doi.org/10.1186/1477-7525-8-138
Todd K, Funk J (1996) The minimum clinically important difference in physician-assigned visual analog pain scores. Acad Emerg Med 3(2):142–146. https://doi.org/10.1111/j.1553-2712.1996.tb03402.x
Haroon M, Haroon R, Akram J (1999) Irritable bowel syndrome—a clinical comparison of mebeverine and phloroglucinol. Pak J Gastroenterol 13:0
Cargill G, Salin B, Lubin S et al (1992) Effect of phloroglucinol on rectosigmoid motility stimulated by a test meal. Study in patients with irritable bowel syndrome. Press Medicale 21:19–23
Louvel D, Delvaux M, Staumont G, Camman F, Fioramonti J, Bueno L, Frexinos J (1996) Intracolonic injection of glycerol: a model for abdominal pain in irritable bowel syndrome? Gastroenterology 110(2):351–361. https://doi.org/10.1053/gast.1996.v110.pm8566580
Chen N-J, Cheng B, Liao J-Z, Li RX, Hu JF, Yang YZ (2011) Clinical application of phloroglucinol in special endoscopic treatment for esophageal diseases. World Chinese J Dig 19(17):1834–1838. https://doi.org/10.11569/wcjd.v19.i17.1834
García-Perdomo HA, Echeverría-García F, López H, Fernández N, Manzano-Nunez R (2017) Pharmacologic interventions to treat renal colic pain in acute stone episodes: systematic review and meta-analysis. Prog Urol 27(12):654–665. https://doi.org/10.1016/j.purol.2017.05.011
Pathan SA, Mitra B, Straney LD, Afzal MS, Anjum S, Shukla D, Morley K, Hilli SAA, Rumaihi KA, Thomas SH, Cameron PA (2016) Delivering safe and effective analgesia for management of renal colic in the emergency department: a double-blind, multigroup, randomised controlled trial. Lancet 387(10032):1999–2007. https://doi.org/10.1016/S0140-6736(16)00652-8
Dellabella M, Milanese G, Muzzonigro G (2005) Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol 174(1):167–172. https://doi.org/10.1097/01.ju.0000161600.54732.86
Hübner WA, Irby P, Stoller ML (1993) Natural history and current concepts for the treatment of small ureteral calculi. Eur Urol 24(2):172–176. https://doi.org/10.1159/000474289
Chen T-D, Wang Y-H, Yang L-Y et al (2010) Phloroglucinol: safe and effective for the prevention of bladder spasm after TURP. Zhonghua nan ke xue / Natl J Androl 16:1004–1006
Romics I, Molnár DL, Timberg G, Mrklic B, Jelakovic B, Köszegi G, Blaskó G (2003) The effect of drotaverine hydrochloride in acute colicky pain caused by renal and ureteric stones. BJU Int 92(1):92–96. https://doi.org/10.1046/j.1464-410X.2003.04262.x
Surdea-Blaga T, Baban A, Nedelcu L, Dumitrascu DL (2016) Psychological interventions for irritable bowel syndrome. J Gastrointest Liver Dis 25(3):359–366. https://doi.org/10.15403/jgld.2014.1121.253.ibs
Patel S, Stason W, Legedza A et al (2005) The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil 17(3):332–340. https://doi.org/10.1111/j.1365-2982.2005.00650.x
Boussageon R, Huas C, Rat C, et al (2017) Reconstruire l’Evidence Based pour une décision médicale partagée. Evaluation de l’efficacité et de la sécurité des médicaments fondée sur une revue systématique des essais cliniques randomisés et des méta-analyses. Exercer 130:90–4
Author information
Authors and Affiliations
Contributions
Clara Blanchard: performed the research, analysed the data and wrote the paper.
Denis Pouchain: contributed to the writing of the paper and to the analysis of the data.
Paul Vanderkam: contributed to the writing of the paper.
Marie-Christine Perrault-Pochat: contributed to the analysis of the data.
Remy Boussageon: conceived the study and analysed the data.
Hélène Vaillant-Roussel: analysed the data and contributed to the writing of the paper.
Corresponding author
Electronic supplementary material
ESM 1
(DOCX 22 kb)
Rights and permissions
About this article
Cite this article
Blanchard, C., Pouchain, D., Vanderkam, P. et al. Efficacy of phloroglucinol for treatment of abdominal pain: a systematic review of literature and meta-analysis of randomised controlled trials versus placebo. Eur J Clin Pharmacol 74, 541–548 (2018). https://doi.org/10.1007/s00228-018-2416-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-018-2416-6